In vivo experiments on gastric cancer, especially the highest level of ADAM9 overexpression at infiltrating border cells bordering non-cancerous epithelial cells, which are mainly distributed in the cell membrane and cytoplasm, which leads to a decrease in the invasion rate by inhibiting the EGFR/ERK signaling pathway. The gene discussed is ADAM9; the disease is gastric cancer.